- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05060640
ANAL PRECANCEROUS LESIONS IN HIGH-RISK PATIENTS. (PACCO)
December 9, 2022 updated by: University Fernando Pessoa
PREVALENCE OF ANAL PRECANCEROUS LESIONS IN HIGH-RISK PATIENTS DETECTED BY ROUTINE COLONOSCOPY (PACCO STUDY)
HIV-positive patients, women with a history of genital neoplasia and patients under pharmacologically immunosuppression (e.g.
transplanted recipients, Crohn´s disease and Lupus) are a high-risk population for anal human-papillomavirus infection and associated complications, like anal precancerous lesions and anal squamous cell carcinoma.
There is a lack of information on the prevalence of anal precancerous detected by routine colonoscopy in this population, by evaluating the squamocolumnar junction (the most susceptible area for lesions) during this procedure.
Given, the increasing incidence rates of anal squamous cell carcinoma expected for the next two decades and the increase number of at-risk patients, the possible benefit of routine endoscopy in the diagnosis of anal precancerous lesions needs to be further explored.
Study Overview
Status
Recruiting
Intervention / Treatment
Detailed Description
Procedures in all patients:
- Digital anorectal evaluation
- Colonoscopy with retroflection and visualization of the anal squamocolumnar junction
- After identification of this area 5% acetic acid will be applied.
- Visualization under NBI/BLI.
- Biopsies of all the suspected lesions of anal high-grade squamous lesions (HSIL).
Study Type
Observational
Enrollment (Anticipated)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Andreia Albuquerque, MD PhD
- Phone Number: 00351222455455
- Email: a.albuquerque.dias@gmail.com
Study Locations
-
-
Porto
-
Gondomar, Porto, Portugal, 4420-096
- Recruiting
- Fernando Pessoa Teaching Hospital
-
Contact:
- Andreia Albuquerque, MD PhD
- Phone Number: 00351965501747
- Email: a.albuquerque.dias@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
HIV-positive patients, women with genital neoplasia (cervix, vulva and vagina), solid organ transplanted recipients, patients with inflammatory bowel disease and patients with Lupus.
Description
Inclusion Criteria:
- HIV-positive patients
- Solid transplanted recipients
- Crohn's disease patients under immunosuppression: steroids, thiopurines, biologics
- Patients with lupus under immunosuppression
- Women with a previous history of genital neoplasia (high-grade lesions or cancer) in the cervix, vagina or vulva.
Exclusion Criteria:
- Previous anal/perianal cancer history
- Previous known history of anal/perianal intraepithelial neoplasia
- Pelvic radiation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Prevalence of anal high-grade squamous intraepithelial lesions in the squamocolumnar junction detected during routine colonoscopy.
Time Frame: through study completion, an average of 3 years
|
through study completion, an average of 3 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 26, 2021
Primary Completion (Anticipated)
August 31, 2024
Study Completion (Anticipated)
August 31, 2024
Study Registration Dates
First Submitted
September 17, 2021
First Submitted That Met QC Criteria
September 28, 2021
First Posted (Actual)
September 29, 2021
Study Record Updates
Last Update Posted (Estimate)
December 12, 2022
Last Update Submitted That Met QC Criteria
December 9, 2022
Last Verified
December 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 78A
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HSIL, High Grade Squamous Intraepithelial Lesions
-
Hospital Universitari Vall d'Hebron Research InstituteNot yet recruitingRecurrence | HSIL, High Grade Squamous Intraepithelial Lesions
-
Medtronic - MITGCompletedAnal Intraepithelial Neoplasia (AIN) | High-grade Squamous Intraepithelial Lesions (HSIL)United States
-
David FinchLancashire Teaching Hospitals NHS Foundation TrustNot yet recruitingAnal Intraepithelial Neoplasia | Anal High-grade Squamous Intraepithelial Lesion | Anal HSIL
-
Inovio PharmaceuticalsCompletedCervical Dysplasia | Cervical High Grade Squamous Intraepithelial Lesion | HSILUnited States, Spain, Lithuania, Estonia, South Africa, Argentina, Brazil, Finland, Poland, Puerto Rico
-
Antiva BiosciencesCompletedCervical Cancer | Human Papilloma Virus | HSIL, High Grade Squamous Intraepithelial Lesions | Cervical Dysplasia | HSIL of Cervix | High-Grade Cervical Intraepithelial Neoplasia | HIV Negative | CIN - Cervical Intraepithelial Neoplasia | Cervical NeoplasmSouth Africa
-
Fujian Maternity and Child Health HospitalRecruitingHPV Infection | Virus Integration | HSIL, High Grade Squamous Intraepithelial LesionsChina
-
Muğla Sıtkı Koçman UniversityCompletedOxidative Stress | Low Grade Squamous Intraepithelial Lesion | High-Grade Squamous Intraepithelial LesionsTurkey
-
Barretos Cancer HospitalFundação de Amparo à Pesquisa do Estado de São Paulo; Farmoquimica S.A.; Hospital...Not yet recruitingBiomarkers | HSIL, High-Grade Squamous Intraepithelial Lesions | Vaginal Microbiome
-
Newish Technology (Beijing) Co., Ltd.RecruitingHigh-grade Squamous Intraepithelial Lesion (HSIL)China
-
Inovio PharmaceuticalsCompletedHuman Papillomavirus (HPV) | Vulvar Dysplasia | Vulvar Intraepithelial Neoplasia (VIN) | Vulvar High Grade Squamous Intraepithelial Lesion (HSIL) | VIN2 | VIN3 | Pre-cancerous Lesions of the VulvaUnited States
Clinical Trials on Detection of anal HSIL in a routine colonoscopy.
-
Hospital Universitario de CanariasCompletedColorectal Cancer | Screening Uptake of Colonoscopy and FITSpain
-
Erasmus Medical CenterGilead SciencesCompletedAspergillosis, Invasive PulmonaryNetherlands
-
Centre Hospitalier Universitaire de BesanconRecruitingPre-Exposure ProphylaxisFrance
-
University of LatviaUniversity of Ulm; Universitaet InnsbruckRecruitingColorectal Cancer | Polyp of ColonLatvia
-
Peking University Third HospitalRecruiting
-
University of LatviaTechnion, Israel Institute of Technology; Riga East University Hospital; JLM...Enrolling by invitationLiver Cirrhosis | Inflammatory Bowel Diseases | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Peptic Ulcer | Tuberculosis | Pancreatitis, Chronic | Liver Cancer | Colorectal Adenoma | Intestinal Metaplasia | Colorectal Polyp | Gastric Dysplasia | Atrophic Gastritis | Other Infectious Diseases | Flu, HumanLatvia
-
Assoc. Prof. Jiri Kriz, MD, PhDRecruitingSpinal Cord Injuries | Autonomic DysreflexiaCzechia
-
Akdeniz UniversityRecruiting
-
Azienda USL ModenaCompleted
-
Assiut UniversityNot yet recruiting